Zentalis Pharmaceuticalsllc Stock Probability of Future Stock Price Finishing Under 17.15
| ZNTL Stock | USD 12.71 0.17 1.32% |
Closest to current price Zentalis long CALL Option Payoff at Expiration
Zentalis |
Zentalis PharmaceuticalsL Target Price Odds to finish below 17.15
The tendency of Zentalis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 17.15 after 90 days |
| 12.71 | 90 days | 17.15 | close to 99 |
Based on a normal probability distribution, the odds of Zentalis PharmaceuticalsL to stay under $ 17.15 after 90 days from now is close to 99 (This Zentalis PharmaceuticalsLlc probability density function shows the probability of Zentalis Stock to fall within a particular range of prices over 90 days) . Probability of Zentalis PharmaceuticalsL price to stay between its current price of $ 12.71 and $ 17.15 at the end of the 90-day period is about 76.81 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.79 . This usually means as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Zentalis PharmaceuticalsL will likely underperform. Additionally Zentalis PharmaceuticalsLlc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Zentalis PharmaceuticalsL Price Density |
| Price |
Predictive Modules for Zentalis PharmaceuticalsL
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zentalis PharmaceuticalsL. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Zentalis PharmaceuticalsL's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Zentalis PharmaceuticalsL Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Zentalis PharmaceuticalsL is not an exception. The market had few large corrections towards the Zentalis PharmaceuticalsL's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Zentalis PharmaceuticalsLlc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Zentalis PharmaceuticalsL within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.16 | |
β | Beta against NYSE Composite | 2.79 | |
σ | Overall volatility | 1.29 | |
Ir | Information ratio | -0.02 |
Zentalis PharmaceuticalsL Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zentalis PharmaceuticalsL for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zentalis PharmaceuticalsL can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Zentalis PharmaceuticalsL had very high historical volatility over the last 90 days | |
| Net Loss for the year was (292.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zentalis PharmaceuticalsLlc currently holds about 455.22 M in cash with (207.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.99. | |
| Zentalis PharmaceuticalsL has a frail financial position based on the latest SEC disclosures | |
| Over 96.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Disposition of tradable shares by Vultaggio Vincent of Zentalis PharmaceuticalsL subject to Rule 16b-3 |
Zentalis PharmaceuticalsL Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zentalis Stock often depends not only on the future outlook of the current and potential Zentalis PharmaceuticalsL's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zentalis PharmaceuticalsL's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.4 M | |
| Cash And Short Term Investments | 482.9 M |
Zentalis PharmaceuticalsL Technical Analysis
Zentalis PharmaceuticalsL's future price can be derived by breaking down and analyzing its technical indicators over time. Zentalis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zentalis PharmaceuticalsLlc. In general, you should focus on analyzing Zentalis Stock price patterns and their correlations with different microeconomic environments and drivers.
Zentalis PharmaceuticalsL Predictive Forecast Models
Zentalis PharmaceuticalsL's time-series forecasting models is one of many Zentalis PharmaceuticalsL's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Zentalis PharmaceuticalsL's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Zentalis PharmaceuticalsL
Checking the ongoing alerts about Zentalis PharmaceuticalsL for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Zentalis PharmaceuticalsL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Zentalis PharmaceuticalsL had very high historical volatility over the last 90 days | |
| Net Loss for the year was (292.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zentalis PharmaceuticalsLlc currently holds about 455.22 M in cash with (207.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.99. | |
| Zentalis PharmaceuticalsL has a frail financial position based on the latest SEC disclosures | |
| Over 96.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Disposition of tradable shares by Vultaggio Vincent of Zentalis PharmaceuticalsL subject to Rule 16b-3 |
Check out Zentalis PharmaceuticalsL Backtesting, Zentalis PharmaceuticalsL Valuation, Zentalis PharmaceuticalsL Correlation, Zentalis PharmaceuticalsL Hype Analysis, Zentalis PharmaceuticalsL Volatility, Zentalis PharmaceuticalsL History as well as Zentalis PharmaceuticalsL Performance. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.